🔴 Tenax Therapeutics is trading 5% down today as biotech sector reverses rally

Tenax Therapeutics is trading 5.19% down now at $1.80 after the broader biotech sector reversed Wednesday’s rally.

• XBI is down 2.47% during the regular session as investors take profits following Moderna and Merck’s positive melanoma-vaccine news; rising Treasury yields are pressuring risk-sensitive assets.
• No new company-specific announcement was identified on August 20, 2026.
• The earlier Phase 3 LEVEL failure remains a negative backdrop but does not directly explain today’s sector-led move.